{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:59:00Z","timestamp":1790272740571,"version":"4.1.0"},"reference-count":75,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K23 CA204726"],"award-info":[{"award-number":["K23 CA204726"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>Immune checkpoint inhibitors, including those targeting the programmed cell death 1\/programmed cell death ligand 1 and cytotoxic T lymphocyte antigen 4 pathways, are revolutionizing cancer therapeutics. Both activity and toxicities largely stem from unleashing tumor\u2010 or host\u2010specific cytotoxic T cells. Many patients seen in routine clinical practice have not qualified for or have been seriously underrepresented in immune checkpoint inhibitor clinical trials. Thus, a major gap in knowledge regarding the safety and efficacy of these agents persists in many populations, even after regulatory approval. To address this challenge, this review aggregates and synthesizes the available preclinical and clinical data surrounding immune checkpoint inhibitor therapy in challenging clinical populations to assist both academic and community oncologists in treatment decision making. Specifically, this review focuses on the safety and activity of immune checkpoint inhibitors in patients with autoimmune disorders, organ transplant patients, patients with chronic viral infections, patients with ongoing immunosuppressant use, patients with organ dysfunction, pregnant patients, patients with brain metastases, patients at extremes of age, and patients with an impaired functional status. <jats:bold><jats:italic>Cancer<\/jats:italic> 2017;123:1904\u20131911<\/jats:bold>. \u00a9 <jats:italic>2017 American Cancer Society<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/cncr.30642","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T16:12:40Z","timestamp":1488211960000},"page":"1904-1911","source":"Crossref","is-referenced-by-count":303,"title":["Immune checkpoint inhibitors in challenging populations"],"prefix":"10.1002","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-773X","authenticated-orcid":false,"given":"Douglas B.","family":"Johnson","sequence":"first","affiliation":[{"name":"Department of Medicine Vanderbilt University Medical Center Nashville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Medicine Massachusetts General Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Menzies","sequence":"additional","affiliation":[{"name":"Department of Medicine Melanoma Institute Australia, University of Sydney Royal North Shore and Mater Hospitals Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.045"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.985"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1020"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1603892113"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2238"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4368"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw443"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5204"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.034"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.08.014"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.08.007"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85796"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168468"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601202"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.07.026"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw130"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-015-0066-0"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000077"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.2314"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2016.07.019"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1213835"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26257"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.346"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.266"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7177"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13786"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0171-8"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1918-2"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2764-1"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.111"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2651-9"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1509268"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0307168"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4875"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1482"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05115"},{"key":"e_1_2_14_39_1","first-page":"737389","article-title":"PD\u20101 blockade in advanced melanoma in patients with hepatitis C and\/or HIV","volume":"2015","author":"Davar D","year":"2015","journal-title":"Case Rep Oncol Med."},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.18_suppl.lba101"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00083-2"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70076-8"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70090-6"},{"key":"e_1_2_14_44_1","first-page":"84","article-title":"The pharmacokinetics and pharmacodynamics of monoclonal antibodies\u2014mechanistic modeling applied to drug development","volume":"10","author":"Mould DR","year":"2007","journal-title":"Curr Opin Drug Discov Devel."},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0166-5"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00561-4"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32455-2"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0152-y"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.010"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17392"},{"key":"e_1_2_14_51_1","first-page":"756","article-title":"Age on outcome and toxicity with anti\u2013PD\u20101\/PD\u2010L1 therapy in patients with melanoma [abstract]","volume":"28","author":"Bethof A","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"e_1_2_14_52_1","first-page":"379","article-title":"Safety and efficacy of anti\u2013PD\u20101 antibodies in elderly patients with metastatic melanoma","volume":"27","author":"Rai R","year":"2016","journal-title":"Ann Oncol"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.006"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1234572"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0491"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26018"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1829"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12477"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0143"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348"},{"key":"e_1_2_14_61_1","first-page":"25","article-title":"Prognostic factors for survival in patients with inoperable lung cancer","volume":"65","author":"Stanley KE","year":"1980","journal-title":"J Natl Cancer Inst."},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1219"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.04.019"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2378"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603702"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4059"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00049"},{"key":"e_1_2_14_70_1","article-title":"A retrospective analysis of the efficacy of pembrolizumab in melanoma patients with brain metastases","author":"Dagogo\u2010Jack I","journal-title":"J Immunother"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30053-5"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0238"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1214788"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv622"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002031"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.21176"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:26:53Z","timestamp":1760279213000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1002\/cncr.30642"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30642","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}